Cambia Health Plans

Regence and TRHC Partner on COVID-19 Virtual Clinical Trial to Assess Proposed Treatment Risks

Moorestown, NJ, June 9, 2020 – Regence and Tabula Rasa HealthCare® (NASDAQ: TRHC) announced today that the companies have partnered on a virtual clinical trial to assess the risk of adverse drug events (ADEs) associated with drugs repurposed for the treatment of COVID-19. The trial examines de-identified medical information for approximately 500,000 Regence health plan members across multiple lines of business. Regence is a family of health plans in Oregon, Idaho, Utah and select counties... Read More